SMS Lifesciences India has further acquired 10,00,000 equity shares of Rs 10 each (21.21%) in Mahi Drugs on September 17, 2018. With this, the total stake of the company as on date in Mahi Drugs is 100.00% and it has become wholly owned subsidiary of the company.
SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.
